1-1 of 1
C. Delaney, BSN
Close
Save search
Sort by
Journal Articles

Lenalidomide Plus Bortezomib (Rev-Vel) in Relapsed and/or Refractory Multiple Myeloma (MM): Final Results of a Multicenter Phase 1 Trial.

Free
Paul G. Richardson, MD, S. Jagannath, MD, D.E. Avigan, MD, M. Alsina, R.L. Schlossman, MD, A. Mazumder, MD, N.C. Munshi, MD, I. Ghobrial, MD, D. Doss, MD, M.L. McKenney, NP, M.G. Farrell, BS, D.L. Warren, BS, L.E. Lunde, BA, B. Gourley, BA, S. Vaccaro, BS, C. Delaney, BSN, S. Pountney, BS, C.S. Mitsiades, MD, PhD, T. Hideshima, MD, PhD, C. Byrne, RN, R. Knight, MD, A. Birner, Pharm D, T. Myers, MD, E. Weller, PhD, K.C. Anderson, MD
Journal: Blood
Blood (2006) 108 (11): 405.
https://doi.org/10.1182/blood.V108.11.405.405
Published: 2006